• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Retracted] MicroRNA‑1297 inhibits metastasis and epithelial‑mesenchymal transition by targeting AEG‑1 in cervical cancer.[已撤回] 微小RNA-1297通过靶向AEG-1抑制宫颈癌的转移和上皮-间质转化
Oncol Rep. 2022 Sep;48(3). doi: 10.3892/or.2022.8372. Epub 2022 Jul 20.
2
[Retracted] MicroRNA‑153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma.[已撤回] 微小RNA-153是一种预后标志物,通过靶向SNAI1抑制人胰腺导管腺癌中的细胞迁移和侵袭。
Oncol Rep. 2023 Jan;49(1). doi: 10.3892/or.2022.8444. Epub 2022 Nov 16.
3
[Retracted] MicroRNA‑744 inhibits migration and invasion of hepatocellular carcinoma cells by targeting SOX12.[已撤回] 微小RNA-744通过靶向SOX12抑制肝癌细胞的迁移和侵袭。
Oncol Rep. 2022 Sep;48(3). doi: 10.3892/or.2022.8364. Epub 2022 Jul 20.
4
[Retracted] miR‑138 inhibits gastric cancer growth by suppressing SOX4.[已撤回] miR-138通过抑制SOX4抑制胃癌生长。
Oncol Rep. 2022 Mar;47(3). doi: 10.3892/or.2022.8258. Epub 2022 Jan 11.
5
[Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.[已撤回] miR-133a通过靶向表皮生长因子受体抑制宫颈癌生长。
Oncol Rep. 2021 Jul;46(2). doi: 10.3892/or.2021.8103. Epub 2021 Jun 3.
6
[Retracted] MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.[已撤回] 微小RNA-205通过靶向RUNX2在骨肉瘤中发挥肿瘤抑制作用。
Oncol Rep. 2021 Aug;46(2). doi: 10.3892/or.2021.8106. Epub 2021 Jun 10.
7
[Retracted] MicroRNA‑643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma.[已撤回]MicroRNA-643调节ZEB1的表达并抑制骨肉瘤的肿瘤发生。
Mol Med Rep. 2022 Sep;26(3). doi: 10.3892/mmr.2022.12792. Epub 2022 Jul 20.
8
[Retracted] miR‑363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.[已撤回] miR-363通过调控E2F3抑制肝癌细胞的生长、迁移和侵袭。
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8181. Epub 2021 Sep 9.
9
[Retracted] MicroRNA‑195 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation 1 domain containing 1 in cervical cancer.[已撤回] 微小RNA-195通过靶向宫颈癌中含1的cullin类泛素化修饰缺陷1结构域抑制细胞增殖、迁移和侵袭。
Int J Mol Med. 2021 Jul;48(1). doi: 10.3892/ijmm.2021.4973. Epub 2021 Jun 3.
10
[Retracted] miR‑124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.[已撤回] miR-124通过靶向STAT3抑制人视网膜母细胞瘤细胞的增殖和侵袭。
Oncol Rep. 2021 Nov;46(5). doi: 10.3892/or.2021.8193. Epub 2021 Sep 24.

[已撤回] 微小RNA-1297通过靶向AEG-1抑制宫颈癌的转移和上皮-间质转化

[Retracted] MicroRNA‑1297 inhibits metastasis and epithelial‑mesenchymal transition by targeting AEG‑1 in cervical cancer.

作者信息

Wang Zengyan, He Shanyang, Guo Peng, Guo Xu, Zheng Jingxuan

机构信息

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.

Medical Examination Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.

出版信息

Oncol Rep. 2022 Sep;48(3). doi: 10.3892/or.2022.8372. Epub 2022 Jul 20.

DOI:10.3892/or.2022.8372
PMID:35856442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9350964/
Abstract

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the immunohistochemical data shown in Fig. 4C and the cell migration assay data shown in Fig. 3B and D and Fig. 7B and D were strikingly similar to data that had appeared in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38: 3121‑3129, 2017; DOI: 10.3892/or.2017.5979].

摘要

在本文发表后,一位关注此事的读者提醒编辑注意,图4C所示的某些免疫组化数据以及图3B和D、图7B和D所示的细胞迁移试验数据与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中有争议的数据在提交给[杂志名称]之前已在其他地方发表,或已在考虑发表,编辑决定从该期刊撤回本文。在与作者联系后,他们同意撤回本文的决定。编辑就由此造成的不便向读者致歉。[《肿瘤学报道》38: 3121 - 3129, 2017; DOI: 10.3892/or.2017.5979]